Bortezomib-based therapy is effective and well tolerated in frontline and multiply pre-treated Waldenström macroglobulinaemia including BTKi failures: A real-world analysis.

Khwaja, Jahanzaib; Uppal, Encarl; Baker, Robert; Trivedi, Kajal; Rismani, Ali; Gupta, Rajeev; Proctor, Ian; Kyriakou, Charalampia; D'Sa, Shirley

Khwaja, Jahanzaib; Uppal, Encarl; Baker, Robert; Trivedi, Kajal; Rismani, Ali; Gupta, Rajeev; Proctor, Ian; Kyriakou, Charalampia; D'Sa, Shirley.

Affiliation

Khwaja J; Department of Haematology University College London Hospitals London UK.
Uppal E; Department of Haematology University College London Hospitals London UK.
Baker R; Health Services Laboratories London UK.
Trivedi K; Health Services Laboratories London UK.
Rismani A; Department of Haematology University College London Hospitals London UK.
Gupta R; Department of Haematology University College London Hospitals London UK.
Proctor I; Department of Cellular Pathology University College London Hospitals London UK.
Kyriakou C; Department of Haematology University College London Hospitals London UK.
D'Sa S; Department of Haematology University College London Hospitals London UK.